Dna X (SONM) Asset Writedowns and Impairment (2018 - 2025)
Dna X's Asset Writedowns and Impairment history spans 7 years, with the latest figure at $984000.0 for Q4 2025.
- Quarterly results put Asset Writedowns and Impairment at $984000.0 for Q4 2025, down 82.01% from a year ago — trailing twelve months through Dec 2025 was $7.5 million (up 16.22% YoY), and the annual figure for FY2025 was $2.1 million, down 68.11%.
- Asset Writedowns and Impairment for Q4 2025 was $984000.0 at Dna X, down from $1.1 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $5.5 million in Q4 2024 to a low of -$2.2 million in Q3 2024.
- The 4-year median for Asset Writedowns and Impairment is $730000.0 (2021), against an average of $1.1 million.
- The sharpest move saw Asset Writedowns and Impairment crashed 38.31% in 2021, then tumbled 98.35% in 2022.
- Year by year, Asset Writedowns and Impairment stood at $182000.0 in 2021, then tumbled by 98.35% to $3000.0 in 2022, then skyrocketed by 182266.67% to $5.5 million in 2024, then crashed by 82.01% to $984000.0 in 2025.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $984000.0, $1.1 million, and $5.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.